Insight

New allogeneic CAR T cell therapy for advanced kidney cancer and an oncolytic immunotherapy for organ transplant patients with skin cancer – MD Anderson Cancer Center

Photo taken from Heiko Enderling/Twitter

Apr 9, 2024, 13:09

New allogeneic CAR T cell therapy for advanced kidney cancer and an oncolytic immunotherapy for organ transplant patients with skin cancer – MD Anderson Cancer Center

MD Anderson Cancer Center shared on LinkedIn:

”At the 2024 American Association for Cancer Research Annual Meeting, our Samer Srour and Michael Migden presented results from two clinical trials highlighting novel immunotherapy advances, including a new allogeneic CAR T cell therapy for advanced kidney cancer and an oncolytic immunotherapy for organ transplant patients with skin cancer.
Learn about the findings.”

Source: MD Anderson Cancer Center/LinkedIn

2024 American Association for Cancer Research Annual Meeting AACR AACR24 cancer CAR T-cell therapy Cell Therapy clinical trials immunotherapy kidney cancer MD Anderson Cancer Center Michael Migden OncoDaily Oncology Samer Srour skin cancer

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage